Research Progress on the Clinical Application and Mechanism of Action of Ephedra
- Author:
- No author available
- Journal Title:
- Chinese Journal of Drug Abuse Prevention and Treatment
- Issue:
- 1
- DOI:
- 10.15900/j.cnki.zylf1995.2024.01.019
- Key Word:
- 麻黄;肺系疾病;心脑血管疾病;肾病;麻黄碱;伪麻黄碱;药理毒性;Ephedra;Pulmonary diseases;Cardiovascular and cerebrovascular diseases;Kidney disease;Ephedrine;Pseudoephedrine;Pharmacotoxicity
Abstract： Ephedra is one of the commonly used drugs in traditional Chinese medicine clinical practice,which has the effects of sweating,relieving external symptoms,promoting lung function,relieving asthma,promoting diuresis,and reducing swelling.It has significant effects in the treatment of lung diseases,cardiovascular and cerebrovascular diseases,kidney diseases,and other diseases.The main active ingredients of ephedra are ephedrine,pseudoephedrine,flavonoids,ephedra polysaccharides,etc.They have various functions such as antibacterial,antiviral,immune regulation,antioxidant activity,etc.However,ephedra has certain pharmacological toxicity.Clinical practice should pay attention to strict control of related products,prohibit excessive dosage and long-term use,and ensure medication safety.This article mainly reviews the clinical application and mechanism of action of ephedra,aiming to provide reference basis for clinical application and ephedra research.
- [1]陈宏,张明浩,陈群,等.麻黄-细辛药对提取物对哮喘模型小鼠气道重塑的影响[J].2023,45(2).
- [2]杨东武.麻黄桂枝汤联合西药治疗寒痰阻肺型慢性支气管炎的临床研究[J].2021,(18).
- [3]白玉臣.盐酸麻黄碱滴鼻液致慢性幻觉症2例[J].2014,(9).
- [4]梁军,王舒,苑宏宇,等.麻黄多糖对PM2.5联合卵白蛋白诱导哮喘小鼠血清代谢组学的研究[J].2023,51(4).
- [5]侯平,杨丽,刘宁,等.麻黄碱、β-细辛醚和去甲乌药碱对大鼠心肌细胞钙离子浓度和细胞膜钙通道的影响[J].2013,(3).
- [6]楚彩云.通窍活血汤合麻黄附子细辛汤加减治疗中风后抑郁症（血行瘀滞证）的临床研究[D].2012.
- [7]邱芸.预注小剂量麻黄碱对全麻诱导期心血管系统的防护作用[J].2013,(8).
- [8]许良葵.基于TLR4/MyD88/MAPK通路探讨桂枝--麻黄调控脑缺血后炎症反应的作用机制[D].2018.
- [9]王艳宏,王秋红,夏永刚,等.麻黄化学拆分组分的性味药理学评价--麻黄化学拆分组分“辛宣苦泄”平喘作用的研究[J].2011,(24).
- [10]郑勇飞,陈礼平,叶益平,等.麻黄升麻汤加减治疗重型新型冠状病毒肺炎1例[J].2021,(2).
- [11]李睿明,张明升.加味麻黄附子细辛汤提取物对缺血再灌注诱发新西兰兔房室传导阻滞的影响[J].2008,(12).
- [12]邵秋莲.含麻黄碱复方制剂监管中存在的问题与对策[J].2013,(8).
- [13]左琳,陈志祥,张华,等.加味射干麻黄汤联合孟鲁司特钠对支气管哮喘患者肺功能的影响[J].2022,17(17).
- [14]贺卫川.麻黄附子细辛汤辅治肾病综合征太少两感证疗效观察[J].2022,38(12).
- [15]亓四广.麻黄连翘赤小豆汤对急性肾小球肾炎患儿肾功能及血清炎性因子水平的影响[J].2022,37(1).
- [16]黄山,刘纳文,郝阳.经方麻黄附子细辛汤合防己黄芪汤减轻膜性肾病小鼠氧化应激损伤的机制研究[J].2022,39(11).
- [17]刘朋燕,张颖,史书阁.麻黄附子细辛汤辅助治疗肥厚型梗阻性心肌病疗效观察[J].2022,45(2).
- [18]赵云生,毛福英,姚海花,等.麻黄多糖发汗、止咳与利尿活性研究[J].2014,(16).
- [19]郑萍,戴贵东,李汉青.麻黄碱及伪麻黄碱药理作用研究进展[J].2002,(2).
- [20]徐进.运用麻黄附子细辛汤治疗肾病综合征的临床疗效观察[J].2018,(z1).
- [21]于立杰,肖荷妹,李凤丹,等.大黄麻黄方对大鼠血压及血浆肾素-血管紧张素-醛固酮系统的影响[J].2016,(11).
- [22]詹中利.麻黄碱致帕金森病严重高血压反应一例[J].2010,(4).
- [23]彭欣,秦林.从清肺排毒汤辨治新型冠状病毒肺炎论麻黄在温热病中的应用[J].2022,46(1).
- [24]怀立春.麻黄碱注射液引起频发性室性期前收缩2例[J].2012,(6).
- [25]王娇.麻黄水提物雾化吸入对支气管哮喘小鼠气道炎症的影响[D].2011.
- [26]张文静,郭桂明,许佳旺,等.基于关联规则的31958张含麻黄中药制剂处方用药分析[J].2021,(12).
- [27]张水馨.基于Ca2+-CaM-CaMKⅡ信号传导通路的麻黄附子细辛汤对CaM/CaMKⅡ的影响[D].2014.
- [28]郑芳昊,罗佳波.麻黄对大鼠中枢神经系统毒副作用的研究[J].2015,(3).
- [29]解成喜,符继红,张丽静.麻黄中挥发油化学成分的分析[J].2004,(3).
- [30]齐佳慧,韩秋菊,王菲,等.木贼麻黄多糖的提取及体外抗氧化活性研究[J].2018,(9).
- [31]王乐,李重阳.麻黄碱检测的研究[J].2021,(2).
- [32]范珊珊,李灿,邢淑雁,等.麻黄细辛附子汤对肾阳虚外感小鼠及正常小鼠的效-毒作用研究[J].2020,(7).
- [33]Lee, Ah Young,Jang, Yoonjeong,Hong, Seong-Ho,etc.Ephedrine-induced mitophagy via oxidative stress in human hepatic stellate cells[J].2017,42(4).
- [34]孙启慧,付业佩,李灿,等.基于代谢组学方法研究麻黄细辛附子汤治疗肾阳虚外感小鼠的作用机制[J].2018,(5).